Helicobacter pylori in health and disease.

Helicobacter pylori is highly adapted for colonization of the human stomach and is present in about half of the human population. When present, H pylori is usually the numerically dominant gastric microorganism. H pylori typically does not cause any adverse effects, but it is associated with an increased risk of noncardia gastric adenocarcinoma, gastric lymphoma, and peptic ulcer. Disorders such as esophageal diseases and childhood-onset asthma were recently reported to occur more frequently in individuals who lack H pylori than in H pylori-positive persons. In this review, we discuss biologic factors that allow H pylori to colonize the human stomach, mechanisms by which H pylori increases the risk of peptic ulcer disease and noncardia gastric adenocarcinoma, and potential benefits that H pylori might confer to humans.

[1]  S. Brandt,et al.  Importance of EGF receptor, HER2/Neu and Erk1/2 kinase signalling for host cell elongation and scattering induced by the Helicobacter pylori CagA protein: antagonistic effects of the vacuolating cytotoxin VacA , 2009, Cellular microbiology.

[2]  F. Islami,et al.  Helicobacter pylori and Esophageal Cancer Risk: A Meta-analysis , 2008, Cancer Prevention Research.

[3]  K. Ottemann,et al.  Recombination-Based In Vivo Expression Technology Identifies Helicobacter pylori Genes Important for Host Colonization , 2008, Infection and Immunity.

[4]  Anders F. Andersson,et al.  Comparative Analysis of Human Gut Microbiota by Barcoded Pyrosequencing , 2008, PloS one.

[5]  M. Rugge,et al.  Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. , 2008, Gastroenterology.

[6]  M. Blaser,et al.  Leptin and ghrelin in relation to Helicobacter pylori status in adult males. , 2008, The Journal of clinical endocrinology and metabolism.

[7]  K. Robinson,et al.  Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses , 2008, Gut.

[8]  C. Bevins,et al.  Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner. , 2008, Gastroenterology.

[9]  K. Hardie,et al.  Functional association between the Helicobacter pylori virulence factors VacA and CagA. , 2008, Journal of medical microbiology.

[10]  R. Lorenz,et al.  Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. , 2008, Gastroenterology.

[11]  Naomi Ohnishi,et al.  Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse , 2008, Proceedings of the National Academy of Sciences.

[12]  D. Busch,et al.  Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. , 2008, Cell host & microbe.

[13]  Yu Chen,et al.  Does Helicobacter pylori protect against asthma and allergy? , 2008, Gut.

[14]  Yu Chen,et al.  Helicobacter pylori colonization is inversely associated with childhood asthma. , 2008, The Journal of infectious diseases.

[15]  David A. Baltrus,et al.  Natural Transformation Increases the Rate of Adaptation in the Human Pathogen Helicobacter pylori , 2007, Evolution; international journal of organic evolution.

[16]  Roland Hartig,et al.  Helicobacter exploits integrin for type IV secretion and kinase activation , 2007, Nature.

[17]  M. Blaser,et al.  The equilibria that allow bacterial persistence in human hosts , 2007, Nature.

[18]  Mark S. Sundrud,et al.  Helicobacter pylori Vacuolating Cytotoxin Inhibits Activation-Induced Proliferation of Human T and B Lymphocyte Subsets1 , 2007, The Journal of Immunology.

[19]  G. Rieder,et al.  Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. , 2007, Cell host & microbe.

[20]  M. S. McClain,et al.  Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain , 2007, Proceedings of the National Academy of Sciences.

[21]  M. Plummer,et al.  Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. , 2007, Journal of the National Cancer Institute.

[22]  M. Mohagheghi,et al.  A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. , 2007, Gastroenterology.

[23]  M. Blaser,et al.  The association of gastric leptin with oesophageal inflammation and metaplasia , 2007, Gut.

[24]  Kalyani Putty,et al.  Helicobacter pylori Evolution: Lineage- Specific Adaptations in Homologs of Eukaryotic Sel1-Like Genes , 2007, PLoS Comput. Biol..

[25]  C. Josenhans,et al.  Helicobacter pylori evolution and phenotypic diversification in a changing host , 2007, Nature Reviews Microbiology.

[26]  C. Obuse,et al.  Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity , 2007, Nature.

[27]  M. Diamond,et al.  Herpesvirus latency confers symbiotic protection from bacterial infection , 2007, Nature.

[28]  C. Prinz,et al.  Inhibition of T-Cell Proliferation by Helicobacter pylori γ-Glutamyl Transpeptidase , 2007 .

[29]  Yu Chen,et al.  Inverse associations of Helicobacter pylori with asthma and allergy. , 2007, Archives of internal medicine.

[30]  Daniel Falush,et al.  An African origin for the intimate association between humans and Helicobacter pylori , 2007, Nature.

[31]  M. Blaser,et al.  Molecular analysis of human forearm superficial skin bacterial biota , 2007, Proceedings of the National Academy of Sciences.

[32]  C. Prinz,et al.  Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. , 2007, Gastroenterology.

[33]  M. Ege,et al.  The asthma epidemic. , 2006, The New England journal of medicine.

[34]  N. Salama,et al.  Identification of Helicobacter pylori Genes That Contribute to Stomach Colonization , 2006, Infection and Immunity.

[35]  M. Blaser,et al.  Bacterial populations as perfect gases: genomic integrity and diversification tensions in Helicobacter pylori , 2006, Nature Reviews Microbiology.

[36]  T. Haggerty,et al.  Gastroenteritis and Transmission of Helicobacter pylori Infection in Households , 2006, Emerging infectious diseases.

[37]  H. Algood,et al.  Resistance of Primary Murine CD4+ T Cells to Helicobacter pylori Vacuolating Cytotoxin , 2006, Infection and Immunity.

[38]  M. Blaser.  Who are we? , 2006, EMBO reports.

[39]  H. Algood,et al.  Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses , 2006, Clinical Microbiology Reviews.

[40]  H. Mollenkopf,et al.  Cholesterol glucosylation promotes immune evasion by Helicobacter pylori , 2006, Nature Medicine.

[41]  R. Maier,et al.  The diverse antioxidant systems of Helicobacter pylori , 2006, Molecular microbiology.

[42]  M. Pop,et al.  Metagenomic Analysis of the Human Distal Gut Microbiome , 2006, Science.

[43]  H. Mollenkopf,et al.  Characterization of the ArsRS Regulon of Helicobacter pylori, Involved in Acid Adaptation , 2006, Journal of bacteriology.

[44]  L. Bravo,et al.  Effects of a new Helicobacter pylori infection on height and weight in Colombian children. , 2006, Annals of epidemiology.

[45]  J. Atherton,et al.  The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. , 2006, Annual review of pathology.

[46]  Elisabeth M Bik,et al.  Molecular analysis of the bacterial microbiota in the human stomach. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Blaser,et al.  Bacterial biota in reflux esophagitis and Barrett's esophagus. , 2005, World journal of gastroenterology.

[48]  F. Bagnoli,et al.  Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Christian Kraft,et al.  Gain and Loss of Multiple Genes During the Evolution of Helicobacter pylori , 2005, PLoS genetics.

[50]  M. Blaser,et al.  Helicobacter pylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. , 2005, American journal of epidemiology.

[51]  J. Dubochet,et al.  High resolution structural analysis of Helicobacter pylori VacA toxin oligomers by cryo-negative staining electron microscopy. , 2005, Journal of structural biology.

[52]  M. Washington,et al.  Activation of β-catenin by carcinogenic Helicobacter pylori , 2005 .

[53]  H. Aburatani,et al.  Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  A. Aderem,et al.  Evasion of Toll-like receptor 5 by flagellated bacteria. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[56]  Ronald W. Davis,et al.  Microbes on the human vaginal epithelium , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[57]  T. Cover,et al.  Helicobacter pylori VacA, a paradigm for toxin multifunctionality , 2005, Nature Reviews Microbiology.

[58]  K. Robinson,et al.  Host adaptation and immune modulation are mediated by homologous recombination in Helicobacter pylori. , 2005, The Journal of infectious diseases.

[59]  J. Rivera,et al.  The Helicobacter pylori VacA cytotoxin activates RBL‐2H3 cells by inducing cytosolic calcium oscillations , 2004, Cellular microbiology.

[60]  K. Sugano,et al.  Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. , 2005, The Journal of clinical endocrinology and metabolism.

[61]  M. Washington,et al.  Activation of beta-catenin by carcinogenic Helicobacter pylori. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[62]  B. Neilan,et al.  Description of 'Candidatus Helicobacter heilmannii' based on DNA sequence analysis of 16S rRNA and urease genes. , 2004, International journal of systematic and evolutionary microbiology.

[63]  John Bertin,et al.  Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island , 2004, Nature Immunology.

[64]  Y. Sugisaki,et al.  Effect of Helicobacter pylori Infection on Ghrelin Expression in Human Gastric Mucosa , 2004, The American Journal of Gastroenterology.

[65]  S. Perry.  Helicobacter pylori Infection Modifies Immune Response to M. tuberculosis Infection , 2004 .

[66]  H. Isomoto,et al.  Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. , 2004, The American journal of medicine.

[67]  P. Correa,et al.  Helicobacter pylori Arginase Inhibits T Cell Proliferation and Reduces the Expression of the TCR ζ-Chain (CD3ζ)1 , 2004, The Journal of Immunology.

[68]  Mark S. Sundrud,et al.  Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Martin J Blaser,et al.  Bacterial biota in the human distal esophagus , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Joseph K McLaughlin,et al.  Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. , 2004, Journal of the National Cancer Institute.

[71]  M. Fujimiya,et al.  Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  B. P. Guo,et al.  Molecular cloning and characterization of two Helicobacter pylori genes coding for plasminogen-binding proteins , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[73]  M. Blaser,et al.  Helicobacter pylori persistence: biology and disease. , 2004, The Journal of clinical investigation.

[74]  Z. Ackerman,et al.  Role of Helicobacter pylori Infection in Complications from Meckel's Diverticulum , 2003, Digestive Diseases and Sciences.

[75]  P. Correa,et al.  Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). , 2004, Journal of immunology.

[76]  H. Brenner,et al.  Helicobacter pylori colonization and diarrhoeal illness: Results of a population-based cross-sectional study in adults , 2004, European Journal of Epidemiology.

[77]  M. D’Elios,et al.  The Helicobacter pylori Vacuolating Toxin Inhibits T Cell Activation by Two Independent Mechanisms , 2003, The Journal of experimental medicine.

[78]  T. Cover,et al.  Cellular Vacuolation and Mitochondrial Cytochrome c Release Are Independent Outcomes of Helicobacter pylori Vacuolating Cytotoxin Activity That Are Each Dependent on Membrane Channel Formation* , 2003, Journal of Biological Chemistry.

[79]  R. Haas,et al.  Helicobacter pylori Vacuolating Cytotoxin Inhibits T Lymphocyte Activation , 2003, Science.

[80]  C. Caldas,et al.  A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. , 2003, Gastroenterology.

[81]  B. Dove,et al.  Determinants of Non-toxicity in the Gastric Pathogen Helicobacter pylori* , 2003, Journal of Biological Chemistry.

[82]  S. Falkow,et al.  pH-Regulated Gene Expression of the Gastric Pathogen Helicobacter pylori , 2003, Infection and Immunity.

[83]  S. Falkow,et al.  Disruption of the Epithelial Apical-Junctional Complex by Helicobacter pylori CagA , 2003, Science.

[84]  H. Randeva,et al.  Plasma ghrelin following cure of Helicobacter pylori. , 2003, Gut.

[85]  I. Carlstedt,et al.  Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. , 2003, The Journal of infectious diseases.

[86]  R. Haas,et al.  Identification and Characterization of Helicobacter pylori Genes Essential for Gastric Colonization , 2003, The Journal of experimental medicine.

[87]  M. S. McClain,et al.  Essential Role of a GXXXG Motif for Membrane Channel Formation by Helicobacter pylori Vacuolating Toxin* , 2003, The Journal of Biological Chemistry.

[88]  M. Stephens,et al.  Traces of Human Migrations in Helicobacter pylori Populations , 2003, Science.

[89]  T. Cover,et al.  Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. , 2003, Cancer research.

[90]  M. Selbach,et al.  The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c‐Src inactivation , 2003, The EMBO journal.

[91]  N. Jones,et al.  Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein , 2003, Cellular microbiology.

[92]  D. Kelly,et al.  Role of the thioredoxin system and the thiol-peroxidases Tpx and Bcp in mediating resistance to oxidative and nitrosative stress in Helicobacter pylori. , 2003, Microbiology.

[93]  S. Suerbaum,et al.  Helicobacter pylori infection , 2013, Nature Reviews Disease Primers.

[94]  T. Cover,et al.  Two Different Families of hopQ Alleles in Helicobacter pylori , 2002, Journal of Clinical Microbiology.

[95]  C. Caldas,et al.  Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. , 2002, Journal of the National Cancer Institute.

[96]  S. Falkow,et al.  Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[97]  Takeshi Azuma,et al.  Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[98]  C. Sasakawa,et al.  Grb2 is a key mediator of helicobacter pylori CagA protein activities. , 2002, Molecular cell.

[99]  D. Graham,et al.  Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. , 2002, Gastroenterology.

[100]  B. P. Guo,et al.  Rapid genetic analysis of Helicobacter pylori gastric mucosal colonization in suckling mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[101]  D. Philpott,et al.  Reduced activation of inflammatory responses in host cells by mouse‐adapted Helicobacter pylori isolates , 2002, Cellular microbiology.

[102]  R. Rappuoli,et al.  Isogenic mutants of the cag pathogenicity island of Helicobacter pylori in the mouse model of infection: effects on colonization efficiency. , 2002, Microbiology.

[103]  T. Hirayama,et al.  Cutting Edge: VacA, a Vacuolating Cytotoxin of Helicobacter pylori, Directly Activates Mast Cells for Migration and Production of Proinflammatory Cytokines1 , 2002, The Journal of Immunology.

[104]  M. Blaser,et al.  Evidence that cagA+Helicobacter pylori strains are disappearing more rapidly than cagA− strains , 2002, Gut.

[105]  M. Selbach,et al.  Src Is the Kinase of the Helicobacter pylori CagA Protein in Vitro and in Vivo * , 2002, The Journal of Biological Chemistry.

[106]  L. Hammarström,et al.  Helicobacter pylori SabA Adhesin in Persistent Infection and Chronic Inflammation , 2002, Nature Reviews Molecular Cell Biology.

[107]  R. Haas,et al.  Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin‐8 , 2003, Molecular microbiology.

[108]  Takeshi Azuma,et al.  SHP-2 Tyrosine Phosphatase as an Intracellular Target of Helicobacter pylori CagA Protein , 2001, Science.

[109]  O. Berg,et al.  Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[110]  A. Gobert,et al.  Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[111]  Gábor Szabó,et al.  A 12-Amino-Acid Segment, Present in Type s2 but Not Type s1 Helicobacter pylori VacA Proteins, Abolishes Cytotoxin Activity and Alters Membrane Channel Formation , 2001, Journal of bacteriology.

[112]  D. Passaro,et al.  Acute Helicobacter pylori infection is followed by an increase in diarrheal disease among Peruvian children. , 2001, Pediatrics.

[113]  M. Blaser,et al.  Heterogeneity of Helicobacter pylori cag genotypes in experimentally infected mice. , 2001, FEMS microbiology letters.

[114]  T. Azuma,et al.  Gastric leptin and Helicobacter pyloriinfection , 2001, Gut.

[115]  M. Blaser,et al.  Helicobacter pylori genetic diversity and risk of human disease. , 2001, The Journal of clinical investigation.

[116]  F. Mégraud,et al.  cagA Status and Eradication Treatment Outcome of Anti-Helicobacter pylori Triple Therapies in Patients with Nonulcer Dyspepsia , 2001, Journal of Clinical Microbiology.

[117]  M. Blaser,et al.  Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. , 2001, The Journal of clinical investigation.

[118]  S. Falkow,et al.  Vacuolating Cytotoxin of Helicobacter pylori Plays a Role during Colonization in a Mouse Model of Infection , 2001, Infection and Immunity.

[119]  David B. Schauer,et al.  Emergence of Diverse HelicobacterSpecies in the Pathogenesis of Gastric and Enterohepatic Diseases , 2001, Clinical Microbiology Reviews.

[120]  Y. Shiratori,et al.  Virulence Factors of Helicobacter pylori Responsible for Gastric Diseases in Mongolian Gerbil , 2000, The Journal of experimental medicine.

[121]  J. Chambard,et al.  The N‐terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release , 2000, The EMBO journal.

[122]  M. Blaser,et al.  Inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study. , 2000, The Journal of infectious diseases.

[123]  M. Blaser,et al.  Caga-positive strains of Helicobacter pylori may protect against Barrett's esophagus , 2000, American Journal of Gastroenterology.

[124]  D. Graham,et al.  A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[125]  Mark T. Whary,et al.  Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy , 2000, Nature Medicine.

[126]  M. Carrington,et al.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer , 2000, Nature.

[127]  R. Haas,et al.  Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. , 2000, Science.

[128]  L. Brown.  Helicobacter pylori: epidemiology and routes of transmission. , 2000, Epidemiologic reviews.

[129]  S. Falkow,et al.  Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[130]  D. Relman,et al.  Bacterial diversity within the human subgingival crevice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[131]  C. Prinz,et al.  Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[132]  R. Rappuoli,et al.  Formation of anion‐selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity , 1999, The EMBO journal.

[133]  M. Blaser,et al.  Role of Helicobacter pylori cagA+ strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia , 1999, International journal of cancer.

[134]  M. Blaser,et al.  Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. , 1999, The Journal of infectious diseases.

[135]  C. Brändén,et al.  Antibacterial peptide from H. pylori , 1999, Nature.

[136]  F. Mégraud,et al.  Geographic distribution of vacA allelic types of Helicobacter pylori. , 1999, Gastroenterology.

[137]  D. Czajkowsky,et al.  The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[138]  J. M. Smith,et al.  Free recombination within Helicobacter pylori. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[139]  M. Blaser,et al.  Experimental Infection of Mongolian Gerbils with Wild-Type and Mutant Helicobacter pylori Strains , 1998, Infection and Immunity.

[140]  R. Rappuoli,et al.  The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[141]  M. Blaser,et al.  The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. , 1998, Gastroenterology.

[142]  W. Quint,et al.  Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. , 1998, Gastroenterology.

[143]  H. Lönroth,et al.  Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination. , 1998, The Journal of clinical investigation.

[144]  L. Engstrand,et al.  Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. , 1998, Science.

[145]  R. Rappuoli,et al.  Selective Inhibition of Ii-dependent Antigen Presentation by Helicobacter pylori Toxin VacA , 1998, The Journal of experimental medicine.

[146]  R. Hiatt,et al.  Seroprevalence of CagA-positive strains among Helicobacter pylori-infected, healthy young adults. , 1997, The Journal of infectious diseases.

[147]  M. Blaser,et al.  Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. , 1997, Gastroenterology.

[148]  M. Borodovsky,et al.  cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[149]  M. Blaser,et al.  Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. , 1996, The Journal of infectious diseases.

[150]  E. Lesaffre,et al.  Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. , 1996, International journal of epidemiology.

[151]  M. Monteiro,et al.  Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide regions. , 1996, Biochemistry.

[152]  E. Kuipers,et al.  Helicobacter pylori and atrophic gastritis: importance of the cagA status. , 1996, Journal of the National Cancer Institute.

[153]  M. Blaser,et al.  Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori , 1995, The Journal of Biological Chemistry.

[154]  M. Blaser,et al.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. , 1995, Cancer research.

[155]  M. Zerial,et al.  Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[156]  F. Mégraud,et al.  The cohort effect and Helicobacter pylori. , 1993, The Journal of infectious diseases.

[157]  M. Blaser,et al.  Purification and characterization of the vacuolating toxin from Helicobacter pylori. , 1992, Journal of Biological Chemistry.

[158]  I. Helander,et al.  Low biological activity of Helicobacter pylori lipopolysaccharide , 1992, Infection and immunity.

[159]  W. Karnes,et al.  Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. , 1991, Gastroenterology.

[160]  B. Marshall,et al.  Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. , 1990, Gastroenterology.

[161]  D. Zavala,et al.  Risk factors of gastric precancerous lesions in a high-risk Colombian population. I. Salt. , 1990, Nutrition and cancer.

[162]  M. Blaser,et al.  Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. , 1989, The New England journal of medicine.

[163]  B. Marshall,et al.  PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI , 1988, The Lancet.

[164]  D. Graham.  Campylobacter pylori and Barrett's esophagus. , 1988, Mayo Clinic proceedings.

[165]  M. Blaser,et al.  Campylobacter pylori antibodies in humans. , 1988, Annals of internal medicine.

[166]  M. Dixon,et al.  Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. , 1987, Journal of clinical pathology.

[167]  A. Lee,et al.  Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. , 1986, The Journal of infectious diseases.

[168]  B. Marshall,et al.  UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION , 1984, The Lancet.